Virus Versus Virus: ‘ReScan’ Antibody Test is a Powerful New Tool
Scientists at UCSF have developed ReScan, an innovative new serological test that employs a specialized version of the technique known as phage display.
University of California San Francisco
Displaying 1741 - 1770 of 16508
-
-
How Worried Should You Be About the New Coronavirus Variant?
A mutated version of the novel coronavirus has been making the news for being more contagious. We asked UCSF infectious disease expert Charles Chiu, MD, PhD, how the new variant emerged, whether available vaccines will still work, and what we need to do now.
-
Career Office-Alum Collaboration Yields $2.3M Award
-
Brain Cells Most Vulnerable to Alzheimer’s Disease Identified by Scientists
A team of researchers has identified for the first time the neurons that are among the first victims of Alzheimer’s disease.
-
UCSF Administers Second Dose of COVID-19 Vaccine to Frontline Staff
UCSF Medical Center has begun administering second doses of the Pfizer COVID-19 vaccine to frontline employees who are at highest risk of exposure to COVID-19 at work.
-
Health Expert Proposes Distributing Vaccine by Lottery
-
How Fast Can Scientists Find the New Coronavirus Strains?
-
Will Kids Be Safe When They Return to School? Will Everyone Else?
A UCSF pediatrician who is researching methods to control the spread of coronavirus shares why she’s optimistic that schools can reopen safely.
-
‘Invisible’ Stem Cells Evade Natural Killer Cells Using Immune ‘Off-Switch’
UCSF scientists have discovered a new way to control the immune system’s “natural killer” cells, a finding with implications for novel cell therapies and tissue implants that can evade immune rejection.
-
Cancer Metastasis is Target of New Research Initiative
A new research collaborative at UCSF will be focused on decoding the “rulebook” of metastatic cancer as a pathway to new treatments.
-
Seniors Living Alone with Cognitive Impairment Hit Hard by COVID-19 Pandemic
Researchersare calling for tailored services and support for older adults living alone with memory issues, who are experiencing extreme isolation, and are exposed to misinformation about the virus and barriers to accessing medical care.
-
Why CO2 Monitors and Indoor Ventilation May Be a Key to Curb COVID Spread
-
Julius Schachter, Leading Expert on Chlamydia, Dies at 84
-
Expansive Community Investments to Accompany Parnassus Heights Campus Plans
UCSF and the City and County of San Francisco have announced an agreement in principle on a set of community benefits to accompany the University’s Comprehensive Parnassus Heights Plan to modernize its historic campus.
-
Frailty Is a Factor in Higher Mortality for Women Awaiting Liver Transplants
A study headed by UCSF and Columbia University highlights the role that frailty plays in this gender gap.
-
With Musical Life on Hiatus, a Horn Virtuoso Tackles the COVID Pandemic
-
Explanations for ‘Long COVID’ Remain Elusive. For Now, Believing Patients and Treating Symptoms Is the Best Doctors Can Do
-
How Stanford’s Vaccine Algorithm Caused a Major Controversy and Left Frontline Workers at the Back of the Line
-
Allergic Reactions to the Coronavirus Vaccine: Should I Be Concerned?
-
UCSF and BridgeBio Pharma to Accelerate Therapies for Genetic Diseases
UCSF and BridgeBio Pharma, Inc. today announced a partnership to drive the advancement of academic innovations in genetically driven diseases into potential therapeutics for patients.
-
E-Cigarettes, as Consumer Products, Do Not Help People Quit Smoking, Study Finds
A team led by UCSF’s Richard Wang, surveyed the scientific community’s understanding of e-cigarettes and found that, in the form of mass-marketed consumer products, they do not lead smokers to quit.
-
UCSF Doctor Challenges Reports of High COVID-19 Rates in Black Community
-
Autobahn Collaboration to Accelerate UCSF Innovation from Bench to Bedside
Through its Office of Innovation Ventures, UC San Francisco has formalized a new strategic collaboration with Autobahn Labs, a “virtual incubator” focused on drug discovery and development, to help move scientific discoveries with therapeutic potential more quickly to market.
-
‘Race Norming’ Blamed for Denying Payouts to Ex-NFL Players With Dementia
A UCSF clinical psychologist has taken aim at the NFL for “race-norming” Black players diagnosed with dementia, a practice that is depriving them of the monetary awards allocated to former footballers with neurodegenerative disorders.
-
California Lockdown Suppressed Excess Pandemic Deaths
The researchers concluded that the first lockdown from March 19 through May 9 lowered the number of excess deaths for most but not all groups.
-
Should a ‘Vaccine Passport’ Be Required? Experts Weigh in on Future of Eating Out, Boarding Flights, and More
-
Seizure Risk Forecasted Days in Advance with Brain Implant Data
Patterns of brain activity can be used to forecast seizure risk in epilepsy patients several days in advance, according to a new analysis of data obtained from clinically approved brain implants by neuroscientists at UCSF, the University of Bern and the University of Geneva.
-
Vaccination Begins at UCSF – A Watershed Moment in COVID-19 Pandemic
On a history-making day, UCSF began the first vaccinations of its critical health care workforce, including both clinical and non-clinical staff whose work places them at heightened risk of infection by COVID-19.
-
2020: The Year in Review
Amid the challenges of 2020, the tenacity of the UCSF community has allowed us to shine. Take a moment to revisit the highlights from the year, read the science that captured people’s attention, and see moments that exemplify what we do.
-
The Highlights of 2020 at UCSF
It was the year of COVID-19. Of racial reckonings. Of political unrest and transition. Amid these historic events, UCSF adapted, endured and excelled.
